Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel pathogenic mutation in BRCA2 in a Spanish breast-ovarian cancer family.

Genetic testing and molecular biomarkers - 1 Oct 2009

Torres Asuncion, Gumà Josep, Rodríguez Marta, Brunet Joan, Borràs Joan

Abstract excerpt

Germline mutations in the BRCA1/2 genes contribute to most of inherited breast and ovarian cancers. We analyzed a family fulfilling classical criteria of hereditary breast/ovarian cancer. After complete sequencing of coding regions and splice junctions of both genes, a nonpreviously reported muta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Ovarian Neoplasms

Share to Pedigree

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 19715467
DOI: 10.1089/gtmb.2009.0040

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19715467-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel pathogenic mutation in BRCA2 in a Spanish breast-ovarian cancer family.PMID 19715467Read ↗

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.Semantic proximity Read ↗

[The identification of a new mutation in the BRCA2 gene by protein truncation analysis in a Spanish family with hereditary breast cancer].Semantic proximity Read ↗

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.Semantic proximity Read ↗

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.Semantic proximity Read ↗

BRCA1/2 germline missense mutations: a systematic review.Semantic proximity Read ↗

A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history.Semantic proximity Read ↗

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.Semantic proximity Read ↗

Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Mutation analysis of the BRCA2 gene in breast/ovarian cancer Spanish families: identification of two new mutations.Semantic proximity Read ↗

Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil.Semantic proximity Read ↗

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.